IDH1 and central nervous system cancer: Through metabolomics, we found that the reduction of TCA metabolites in IDH-mutated glioma cells with low OGDH expression was more significant compared to that in control cells (Fig. 6c), but TCA cycle enzymes were not significantly altered (Supplementary Fig. S3b).